Search Results - "Benzekry, S."

Combinatorial immunotherapy strategies: most gods throw dice, but fate plays chess by Ciccolini, J., Barbolosi, D., André, N., Benzekry, S., Barlesi, F.

Get full text

Quantitative mathematical modeling of clinical brain metastasis dynamics in non-small cell lung cancer by Bilous, M., Serdjebi, C., Boyer, A., Tomasini, P., Pouypoudat, C., Barbolosi, D., Barlesi, F., Chomy, F., Benzekry, S.

“…Brain metastases (BMs) are associated with poor prognosis in non-small cell lung cancer (NSCLC), but are only visible when large enough. Therapeutic decisions…”
Get full text

Theoretical investigation of the efficacy of antiangiogenic drugs combined to chemotherapy in xenografted mice by Lignet, F., Benzekry, S., Wilson, S., Billy, F., Saut, O., Tod, M., You, B., Adda Berkane, A., Kassour, S., Wei, M.X., Grenier, E., Ribba, B.

“…Antiangiogenic drugs were developed with the aim to inhibit the formation of intratumoral blood vessels and in consequence the growth of solid tumors. As these…”
Get full text

Artificial Intelligence and Mechanistic Modeling for Clinical Decision Making in Oncology by Benzekry, Sebastien

“…The amount of “big” data generated in clinical oncology, whether from molecular, imaging, pharmacological, or biological origin, brings novel challenges. To…”
Get full text

OS06.6 Optimized radiotherapy protocols delay the malignant transformation of low-grade gliomas in-silico by Henares-Molina, A., Benzekry, S., Lara, P., García-Rojo, M., Pérez-García, V., Martínez-González, A.

“…Introduction: The optimal management of grade II gliomas (LGGs) remains controversial, and only limited definitive data is available to guide recommendations…”
Get full text

Combinatorial immunotherapy strategies: most gods throw dice, but fate plays chess by Ciccolini, J, Barbolosi, D, André, N, Benzekry, S, Barlesi, F

Get full text

3MO Comprehensive biomarkers (BMS) analysis to predict efficacy of PD1/L1 immune checkpoint inhibitors (ICIs) in combination with chemotherapy: A subgroup analysis of the precision immuno-oncology for advanced non-small cell lung cancer (pioneer) trial by Barlesi, F., Greillier, L., Monville, F., Audigier Valette, C., Martinez, S., Cloarec, N., Van Hulst, S., Odier, L., Vely, F., Juquel, L., Arnaud, L., Bokobza, S., Hamimed, M., Karlsen, M., Dufosse, P., Pouchin, A., Ghezali, L., Le Ray, M., Fieschi-Meric, J., Benzekry, S.

Get full text